Status:
RECRUITING
Liquid Biospy for Urinary Cancers
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Urothelial Carcinoma
Eligibility:
All Genders
40+ years
Brief Summary
The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transur...
Detailed Description
Bladder cancer (BCa) is the 9th most common cancer worldwide, with an estimated prevalence of around 2.7 million cases and an incidence around 350.000 new cases/year. The proper management of BCa rema...
Eligibility Criteria
Inclusion
- Diagnosis of urothelial neoplasia, naive for therapy
Exclusion
- Absence of previous neolpastic disease or genetic diseases
Key Trial Info
Start Date :
September 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 29 2028
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT06116396
Start Date
September 29 2020
End Date
September 29 2028
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology Department
Milan, Italy, 20132